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Introduction
Forensic: “of, or used, in courts of law” [OED].
People with hypoglycaemia may be brought to the 
attention of the law for a variety of reasons. Most often it 
is due to the legitimate use of insulin leading to temporary 
brain malfunction, that is neuroglycopenia. This may 
result in misbehaviour and offences ranging from abusive 
language in a public place to murder—with petty crime 
and dangerous driving being the most common causes 
for court appearances. A more extensive and detailed 
account of hypoglycaemia as a defence against a criminal 
charge is available elsewhere (1). Rarely hypoglycaemia is a 
consequence of malicious (or accidental) administration of 
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therapeutic insulin and it is with investigation of this type of 
hypoglycaemia that we intend to concentrate in this review.
Therapeutic insulin is not a single substance. Much 
prescribed insulin is still biosynthetic human or animal 
insulin but even more so are synthetic analogues with 
“insulin-like” properties, which may or may not be detected 
by immunoassays for human insulin. Therapeutic insulin—
which includes insulin analogues—is marked with an * to 
distinguish it from human insulin whether endogenous or 
exogenous. Insulin measured by immunoassay is referred to 
as IRI and includes, in addition to human insulin, all animal, 
human and insulin analogues that are detected and semi-
quantitated by immunoassay.
This short article reviews the literature regarding the 
pathophysiology of forensic hypoglycaemia in context 
of the criminal and clinical scenarios, and considers the 
role of the laboratory in contributing to the confirmation 
and elucidation of the aetiology of the hypoglycaemia. 
We present the following article in accordance with the 
Narrative Review reporting checklist (available at http://
dx.doi.org/10.21037/jlpm-20-104).
Hypoglycaemia as a defence against a criminal 
charge
Automatism due to hypoglycaemia is offered as a defence 
to otherwise criminal acts by patients with diabetes. It is, 
however, only tenable if the patient is receiving treatment 
with drugs that are capable of producing biochemical 
hypoglycaemia and not if their treatment is confined to 
diet or drugs, such as metformin, that do not produce 
hypoglycaemia.
Providing the evidence is sufficiently strong a plea of 
automatism is usually accepted by the court and the accused 
walks free (2,3).
Non-iatrogenic or spontaneous hypoglycaemia
In a tiny minority of cases spontaneous hypoglycaemia 
is claimed to be responsible for atypical and motiveless 
criminal behaviour.
While spontaneous hypoglycaemia causing automatism is 
a complete defence to a criminal charge it can only very rarely 
be substantiated. This is due to the rarity of spontaneous 
hypoglycaemia of sufficient severity to produce delinquent 
behaviour but also due to the difficulty of establishing it 
as the cause of the criminal act. This can only be done by 
measuring the accused person’s blood glucose concentration 
at the scene which is unlikely to occur in anything other than 
traffic offences and even then unusual (1).
Although hypoglycaemia due to insulinoma and other 
rare causes of fasting hypoglycaemia may lead to criminal 
behaviour (4), they do so exceedingly rarely and it is usually 
easily diagnosed providing the possibility is considered and 
investigated. Reactive hypoglycaemia, both idiopathic and 
secondary to bariatric surgery, is much more commonly 
offered as a defence and is generally much more difficult 
to prove.
In the past a diagnosis of reactive hypoglycaemia was 
usually made on a clinical history and the result of the long 
discredited “5-hour glucose tolerance test” or the only 
slightly less reliable “breakfast test”. These tests do not 
provide sufficient evidence that a suspect was suffering from 
hypoglycaemia at the time they were purported to have 
committed a criminal offence even though they were often 
accepted as doing so.
Nowadays, in addition to a self-delivered history of 
strange attacks consisting variously of “faintness”, anxiety, 
palpitations, sweatiness, and other symptoms associated 
with acute neuroglycopenia (5), evidence derived from 
ambulatory blood glucose monitoring, preferably with a 
continuous glucose monitoring device, should be required 
before a diagnosis of non-iatrogenic hypoglycaemia is 
seriously entertained (6). Evidence from a glucosidic meal 
test may be useful in suggesting the necessity for continuous 
glucose monitoring (5).
Hypoglycaemia as a criminal offence
Malicious hypoglycaemia is an extremely rare but important 
cause of unexplained hypoglycaemia. It takes many forms 
(Table 1) and the victim may be either dead or alive when 
first seen when they are usually referred to as a patient.
Establishing hypoglycaemia as the cause of the patient’s 
symptoms usually consisting of coma, but sometimes 
just confusion, is relatively easy, whereas establishing 
hypoglycaemia as the cause of death in someone found dead 
though possible may be extremely difficult.
Although the analytical techniques used to investigate 
hypoglycaemia in clinical and potentially forensic situations 
are the same, the data they generate are often more difficult 
to interpret. This is mainly because no reliable clinical 
history is available in the latter case.
A contemporaneous point of care test (POCT) glucose 
level below 3.0 mmol/L may serve as the first clue of 
hypoglycaemia in a patient suspected as being the victim 
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of a crime; it should, however, never be accepted as the 
sufficient evidence to secure a conviction (1,3). This is 
especially true of purported victims of insulin poisoning 
because of the risk of POCT analytical error. It, nevertheless, 
provides an imperative reason for extensive investigation 
and is only likely to occur if every case of unexpected or 
unusual hypoglycaemia is considered potentially criminal 
and a venous sample of blood is collected immediately the 
diagnosis is made. This should be done before treatment with 
intravenous glucose is instituted and can be used later for 
laboratory analyses should it be necessary. This is especially 
true for elderly sick patients who develop hypoglycaemia 
in hospitals or nursing homes and which may be due to 
accidental administration of a hypoglycaemic drug intended 
for someone else, an uncommon response to their underlying 
illness or deliberate poisoning by malicious carers.
Treatment must not be delayed until confirmatory 
laboratory results become available but begin immediately 
after a pre-treatment blood sample has been collected. The 
brief interval between making a provisional diagnosis on the 
basis of the POCT and institution of treatment causes no 
adverse clinical consequence and the failure to collect the 
correct blood samples may have important consequences.
Treatment should commence with a bolus of 50% glucose 
followed by infusion of 10% glucose in amounts sufficient 
to maintain blood glucose within the range 5–12 mmol/L 
until the patient has recovered. A record should be kept of 
the total amount of glucose infused and, if suspicion of foul 
play remains after treatment has begun, analysis of the first 
sample of blood collected should be commenced—if it has 
not already been done!
Further investigations are the same as those for any 
other case of “spontaneous hypoglycaemia” but particular 
attention should be given to “chain of custody” of samples 
collected for analysis. Unless this is done the data obtained 
may be challenged and disregarded by some courts of law.
Interpretation of laboratory data
Patient alive when found
Interpretation of analytical results cannot be done without 
reference to the circumstances under which they were 
requested in forensic cases, any less than in clinical cases—
however much the police or prosecuting authorities would 
like them to be. Every case of unexpected, unexplained 
hypoglycaemia sufficient to cause, or be associated with, 
severe symptoms is potentially suspicious and should be 
treated as such until proved otherwise.
A diagnosis of malicious hypoglycaemia is unlikely unless 
the venous blood glucose concentration is demonstrably 
below 2.5 mmol/L when the diagnosis of hypoglycaemia 
is first made. Although in the living patient, a solitary low 
unexplained POCT glucose result is sufficient reason to 
arouse suspicion and justify further investigation it is far 
from sufficient to establish a diagnosis of hypoglycaemia 
let alone one of malicious hypoglycaemia. In the past this 
Table 1 Classification offences in which insulin (or sulphonylurea) is used as a weapon
Nature of offence Victims Comments
Criminal medical-negligence Patients Accidental administration of insulin  
(sulphonylureas) intended for another patient 
or the over-administration of the prescribed 
medication in a criminally negligent manner
Munchausen-by-proxy and intentional  
harm
Babies and children; frail, elderly, sick people These two conditions merge into one  
another and it is difficult if not impossible 
to differentiate them and from attempted 
murder
Murder and attempted murder Frail, elderly sick and disabled people Sometimes described as “mercy killing”
Solitary individuals—and usually with a motive Exceedingly rare and always by a close  
relative or “friend”
Motiveless mass-killing in hospital or nursing 
homes
Usually by nurse or other health care worker
Deliberate contamination of medicine or  
food with sulphonylurea
Unsuspecting members of the public Occasional epidemics of hypoglycaemia in 
a community
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was not so, and failure to understand this, led to erroneous 
diagnoses and unjustified convictions of nurses for murder 
especially of elderly sick hospital inpatients (7).
Glucose
A blood glucose concentration of greater than 2.5 mmol/L, 
though it may be associated with neuroglycopenic 
symptoms, is extremely unlikely to be due to malicious 
insulin administration; on the other hand no blood glucose 
concentration, however low, is proof that it was. The severity 
of the biochemical hypoglycaemia provides no evidence 
of malicious insulin use—blood glucose concentrations 
below 1.0 mmol/L may occur from a variety of conditions, 
including unrecognised sepsis and acute adrenal failure.
The amount of glucose intravenous needed to keep its 
blood concentration within the desired range of 5–10 mmol/L 
is similarly non-diagnostic. It may, however, provide some 
post-hoc evidence of malicious insulin administration if 
more than about 250 grams during the first 24 hours. Such 
large doses are sometimes required in non-insulin mediated 
hypoglycaemia in sick patients as well as in most cases of 
malicious insulin* or sulphonylurea overdose (1).
Insulin, C-peptide and proinsulin
Blood
Detection and measurement of insulin*, C-peptide and 
proinsulin is fundamental to the making of a diagnosis 
of malicious insulin administration. The three hormones 
should always be interpreted in context of each other, 
although insulin* is clearly the single most important—
especially when analysed by liquid chromatography/mass-
spectrometry (LC-MS) (8)—when identification of a non-
prescribed insulin analogue is pathognomonic.
In the past immunoassay was the only method available 
for measuring insulin* and other peptides in cases of 
suspected homicide but relatively few investigators 
measured C-peptide with or without proinsulin along with 
insulin thereby reducing the diagnostic value of their test 
results as well as its inability to distinguish between it and 
its analogues. Although now this would be considered bad 
practice at best and negligent at worst, it was common in 
the past and reduced the value of the IRI results, however 
accurate they were. Although LC-MS has now replaced 
immunoassay as the definitive method for measuring insulin, 
C-peptide and proinsulin (9,10) especially in forensic 
investigations, immunoassay remains an indispensable 
screening procedure and remains perfectly adequate for 
most clinical work. It is still the only technique available for 
measuring these hormones in many communities.
There is no plasma IRI concentration that is diagnostic of 
felonious insulin administration: an inappropriately high plasma 
insulin (i.e., >100 pmol/L) and appropriately low C-peptide 
(<90 pmol/L), and/or proinsulin (<6 pmol/L) concentration, 
in the presence of a low blood glucose concentration is highly 
suggestive, as is a plasma C-peptide:insulin molar ratio of less 
than 1.0 regardless of the blood glucose concentration. In 
other words the C-peptide:insulin molar ratio can be useful 
even when glucose or glucagon has been given before the first 
(suspicious) blood sample was collected.
A similar pattern, of a higher insulin than C-peptide 
concentration, may also be seen in patients with the 
autoimmune insulin syndrome (AIS) (11,12) or the cause 
may never be found (13).
AIS has been offered as an explanation for elevated 
plasma or serum insulin:C-peptide ratios found in criminal 
cases. Apart from AIS being instantly recognisable by the 
presence of serum insulin auto-antibodies and despite 
having C-peptide:insulin molar ratios of <1.0 the plasma 
C-peptide levels are rarely less than 100 pmol/L in AIS 
whereas in insulin-induced hypoglycaemia they are 
invariably too low to measure.
In the cases of AIS in which the plasma concentration 
of both peptides were reported, C-peptide concentration 
averaged 10,394 (median: 5,000; range: 20–71,3000) pmol/L 
whereas in insulin-induced hypoglycaemia, except in patients 
with severe kidney disease, plasma C-peptide concentrations 
are invariably below the limit of detection. In AIS patients 
the average C-peptide:insulin ratio was 0.42, even exceeded 
a value of 1.0 (8.3%) in three cases. In malicious insulin-
induced hypoglycaemia the plasma C-peptide:insulin ratio 
is less than 0.01, unless glucagon or intravenous glucose has 
already been given when it is still invariable less than 1.0.
Urine
Measurement of insulin in urine is of little diagnostic use as 
its concentration depends as heavily on kidney function as 
on its concentration in blood. Measurement of the urinary 
proinsulin:insulin molar ratio, on the other hand may turn 
out to be very useful for the diagnosis of homicidal insulin 
poisoning.
The normal molar ratio of proinsulin to insulin in urine 
is in the region of 0.14 and is elevated to 0.35 in patients 
with insulinoma (14) in whom plasma proinsulin levels 
are generally raised. It follows therefore, that in cases of 
exogenous hyperinsulinism in which plasma proinsulin 
levels are suppressed, the ratio of urinary proinsulin:insulin 
would be zero. At the time of this writing, however, the 
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urinary proinsulin:insulin ratio has not been mentioned as 
providing valuable evidence in any court case.
The presence of intact molecules of insulin analogues or 
their metabolites by LC-MS is, however, pathognomonic 
when found in the urine of someone for whom they 
were not prescribed. It can be due to either accidental or 
malicious insulin* administration.
Other drugs
Sulphonylureas must always be excluded as the cause of 
unexplained hypoglycaemia. All three plasma pancreatic 
hormones levels are inappropriately high in sulphonylurea 
misuse thereby excluding exogenous insulin but not 
endogenous hyperinsulinism as the cause of a patient’s 
unexplained hypoglycaemia. Although a number of drugs 
and other substances, apart from those used to treat 
diabetes, also produce hypoglycaemia of sufficient severity 
to warrant hospital admission, they do so only sporadically 
and reports of death from this cause are rare. Their mode 
of action is varied and poorly understood but only rarely is 
(endogenous) insulin implicated.
A rigorous toxicological examination of both blood 
and urine is therefore indicated in any case of unexplained 
hypoglycaemia of sufficient severity to cause coma to ensure 
drug-induced hypoglycaemia is not overlooked.
Ketones: ß-hydroxybutyrate
Ketones can replace glucose as a source of energy in many 
tissues and do not require the presence of insulin to do so. 
They are traditionally measured in urine using Rothera’s 
reagents on a dip-stick. Their concentration in blood, as 
represented by ß-hydroxybutyrate (BHB), is not usually 
measured except in patients with diabetes but is helpful 
in distinguishing insulin-induced from most other types 
of hypoglycaemia. Its concentration is decreased to below 
0.6 mmol/L in hypoglycaemia caused by insulin, insulin-like 
growth factors (IGF), extreme malnutrition and liver failure 
whereas in all other conditions causing hypoglycaemia its 
concentration is raised. Consequently, simple measurement 
of plasma BHB may provide an early clue to the correct 
diagnosis and remove the necessity for suspicion in the vast 
majority of cases of unexplained hypoglycaemia.
Lactate
Lactate is the product of the anaerobic breakdown of glucose 
and is normally present in the blood at a concentration 
below 1.8 mmol/L. Its concentration increases when there is 
hypoxia or poor perfusion of tissues. A raised concentration 
of lactate in the blood is therefore indicative of a number 
of disorders many of which, such as sepsis, liver disease or 
heart failure, can also cause hypoglycaemia. Malicious insulin 
usage is not associated with hyperlactataemia and its finding, 
therefore, should arouse suspicion that some other cause 
might have been responsible for the patient’s hypoglycaemia.
The measurement of lactate in post mortem blood and 
especially vitreous humour may be helpful in confirming 
or dismissing a diagnosis of suspected death from 
hypoglycaemia as discussed below.
Alcohol
Alcohol is one of the commonest causes of spontaneous 
hypoglycaemia in patients admitted to hospital and its 
measurement in any case of unexplained hypoglycaemia is 
essential. The concentration of alcohol need not be very 
high to provide evidence of causation since it is possible to 
back-calculate the pre-morbid concentration as long as the 
interval since the last drink is known.
Routine tests for ketones using Rothera’s reagents, 
whether applied to urine or blood, often yield negative 
results since they fail to detect ß-hydroxybutyrate, the main 
ketone raised in alcohol induced hypoglycaemia.
Potassium
Plasma potassium is often subnormal in patients with 
hypoglycaemia whatever the cause. It is invariably below 
4.0 mmol/L in those who have attempted suicide with 
insulin (1), and its measurement may therefore be useful 
in ruling out homicidal insulin administration in cases 
of unexplained hypoglycaemia in which blood insulin 
measurements were not made at the relevant time. While an 
initial plasma potassium concentration below 4.0 mmol/L 
provides no evidence of it causation one above 4.0 mmol/L 
makes a diagnosis of malicious insulin induced hypoglycaemia 
unlikely.
Victim found dead
Murder or manslaughter, using insulin* as the weapon, is 
extremely rare. Unless suspected, however, in every case of 
unexplained death it is likely to go undetected. Conversely, 
the long interval between a person receiving a lethal dose of 
insulin and their demise ensures that the victim will often 
be found in the comatose state that precedes death and be 
saved or left seriously brain damaged (15).
This is especially the case in people who attempt suicide 
with insulin which is the commonest cause of death from 
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malicious insulin use. In both suicide and non-suicide 
cases the victim is often someone who is diabetic or is a 
close relative or friend with easy access to insulin*, but 
occasionally it is someone who has obtained it illicitly. 
Murder using insulin as a weapon by someone unknown 
to the victim is virtually unknown except in cases of mass 
or so-called “mercy” killing by one or more health-care 
workers in a hospital or nursing home environment (16,17).
Investigation of the cause of death by insulin* is the 
same for murder as for suicide but in the latter there are 
often clues to the cause at or near the scene. A minority 
of suicides, however, go to great lengths to hide the cause 
of their death. The interval between the injection and 
its taking effect—usually between 10 and 30 minutes—is 
sufficient to enable them to dispose of the evidence. As a 
result, realisation that a person’s death was due to suicide or 
murder using insulin as the weapon may be delayed for so 
long that realistic laboratory investigation of the cause has 
disappeared.
Typically there are no morphological features that 
identify a corpse as due to insulin poisoning. A thorough 
search of the body may reveal the site of one or more 
injection sites (18), but these may be obscured by being in 
such unlikely sites as the scrotum or vagina that are easy 
to get to but difficult to find. If a site is identified then a 
generous sample of the surrounding tissue should be excised 
at autopsy and sent for immuno-histological examination 
and chemical analysis for insulin*.
Samples of venous blood from a peripheral blood vessel, 
CSF, vitreous humour from both eyes and urine should be 
collected for later analysis in the laboratory. Blood must be 
separated immediately and the serum frozen and kept at 
–200 ℃ until analysed for insulin, C-peptide and proinsulin. 
Haemolysed blood is very unlikely to yield positive results 
when assayed by immunoassay (19), but may contain fragments 
of insulin analogues that are recognised by LC-MS.
Glucose
Glucose disappears from blood so rapidly after death that 
its measurement is of very little value unless undertaken 
within 1 or 2 hours of death—which is unlikely to occur in 
practice. Measurements carried out later may be seriously 
misleading, especially if undertaken on cardiac or central 
venous blood serum when they may be abnormally high, 
even in cases of proven insulin* induced hypoglycaemic 
death. This is due to post-mortem diffusion of glucose from 
the liver into surrounding tissues and blood.
Glucose also disappears from vitreous humour after 
death, contrary to what was once thought and still believed 
by some pathologists. Nevertheless, a vitreous glucose 
concentration of less than 1 mmol/L may provide the first 
clue to an unsuspected insulin-induced death. Even such low 
concentrations are, however, very weak evidence on their 
own of ante mortem hypoglycaemia and are only slightly 
improved by combining its measurement with that of lactate 
in the so-called Traub formula. A combined glucose and 
lactate (Traub) concentration of less than 3 mmol/L indicates 
ante mortem hypoglycaemia regardless of cause and always 
warrants further investigation. A Traub concentration of 
more than 7 mmol/L effectively rules out the diagnosis of 
death from hypoglycaemia.
Insulin, C-peptide and proinsulin
All three peptides disappear from the blood after death and 
unless samples are collected from a peripheral vein within 
24–48 hours of death are unlikely to yield meaningful 
results. This is in part due to the inevitable post mortem 
haemolysis (18), and partly to enzymatic degradation. 
Blood collected from the heart or inferior vena cava may be 
contaminated by insulin diffusing out of the pancreatic islets 
and so is next to useless for analysis by immunoassay but 
may reveal the presence of an unauthorised insulin analogue 
when analysed by LC-MS. Although haemolysed serum 
is unsuitable for immunoassay, it may be suitable when 
analysed by LC-MS for identifying fragments of insulin 
analogues which should not have been there.
The absence of insulin* from non-haemolysed post-
mortem blood serum, collected within 24–48 hours of death 
makes homicide, either suicidal or murderous, unlikely but not 
impossible. In the relatively few cases reported in the literature 
in which a valid measurement was made in post-mortem, 
serum IRI concentrations ranged from 50–10,000 pmol/L 
—the higher levels invariable being reported in suicides. 
Although insulin* is only rarely detected in peripheral blood 
more than 48 hours after death it remains for longer at the 
injection site, if one can be identified, and may be detected 
by immunohistology or preferably by chemical analysis. How 
long insulin may be present at an injection site post mortem is 
unknown but it is unlikely that claims that it is still detectable 
in putrefying exhumed bodies, 6 or more months after burial, 
will be substantiated by chemical analysis—the sine qua non 
for diagnosis.
Serum C-peptide measurements from victims of 
malicious insulin administration are rare but those that have 
been made are invariably low. Measurements of proinsulin 
are even rarer and have not contributed to the diagnosis.
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The measurement of insulin in vitreous humour is 
comparative new but has already established itself as the 
preferred test for identification of suicidal/homicidal insulin 
misuse. It has the advantage that no haemolysis is possible 
though proteolysis continues. Consequently, though insulin 
levels are normally much lower than in blood they decline 
more slowly after death and therefore may be measured and 
identified many days post mortem.
In non-diabetic persons, both ante mortem and post 
mortem vitreous IRI levels are invariably below 10 pmol/L 
and usually immeasurably low; somewhat surprisingly levels 
greater than this, but below 20 pmol/L are sometimes found 
in diabetic patients on insulin therapy (20,21). The mean 
concentration of insulin* in vitreous in the 11 patients in whom 
it is known to have been measured, and to have died from 
insulin poisoning, was 28 pmol/L; range: <10–618 pmol/L; 
median: 150 pmol/L. The one patient in whom vitreous 
insulin* was undetectable had survived 10 days before dying.
Immunohistology
Insulin persists at its site of injection for periods of several 
days depending on its formulation and dosage. The former 
is especially important when the dosage is small but with 
the bigger doses encountered in most suicides even rapidly 
acting formulations may persist for several days. Exactly how 
long maliciously administered insulin remains detectable 
after death is a moot point and depends both upon how long 
the victim survived before dying and how great time elapsed 
between death and the post-mortem and whether the corpse 
was chilled or frozen (22). Most authorities have concluded 
that no insulin remains at an injection site if the post-mortem 
is delayed beyond about 10 days.
Immunohistological examination for insulin of tissue 
removed from around the site of a suspicious injection site is 
often rewarding (23). It should not, however, be accepted as 
irrefutable evidence of malicious insulin misuse in a corpse 
unless confirmed by chemical analysis of a tissue extract. 
Identification of the insulin type by LC-MS is a bonus (10).
Reports of immune histochemical identification of 
insulin in exhumed corpses, many months after death, and 
after putrefaction has set-in, are barely credible and immune 
histochemical diagnosis of insulin homicide is unacceptable 
as evidence of malicious insulin usage in a corpse more than 
1 month after death unless supported by incontrovertible 
chemical evidence (10,24).
Neuropathology
The brain is the only organ anatomically damaged by 
prolonged hypoglycaemia. Its detailed anatomical and 
histological examination is therefore an integral part of 
a suspected death from malicious insulin use. The whole 
brain should be preserved intact before being subject to 
examination by a neuropathologist. While there is evidence 
to suggest that some of the anatomical damage observed 
in hypoglycaemic deaths is due to attempts at too rapid 
restoration of normoglycaemia (25), there are some changes 
that are believed to be produced by hypoglycaemia per se. 
There is, however, still considerable debate as to whether 
neuropathological changes in the brain produced by 
hypoglycaemia are sufficiently distinct from those produced 
by hypoxia to be certain of securing a conviction in cases 
where supporting biochemical evidence is lacking.
The regions of the brain that are affected most are the 
cerebral cortex and the hippocampus but authorities differ 
as to whether any of the changes are diagnostic. The brain 
stem is usually preserved which helps explain the persistent 
vegetative state of those who survive malicious insulin 
use after prolonged but unsuccessful treatment of their 
hypoglycaemic state.
Suicide with insulin or sulponylurea
The study of insulin suicides, and more especially of failed 
suicides (26), has provided much of the information about 
the forensic toxicology of insulin but much remains to be 
learned. Suicide always involves a coroner and usually an 
inquest takes place at which expert advice may be sought.
Suicide, and more commonly its attempt, is no longer 
a crime in most jurisdictions in the world but still carries 
opprobrium and shame in many communities. It may also 
jeopardize life insurance and other civil contracts. Insulin*+ 
as a suicidal agent may not only be used by patients with 
diabetes, their close relatives and friends but also those 
without any known connection with diabetes who access it 
either legally or illegally.
It is important in diabetic patients to distinguish suicide 
with insulin* from accidental death due to its legitimate 
use. This is usually extremely easy due to clues such as a 
suicide note or a collection of insulin vials by their bedside; 
it may also be extremely difficult. A post mortem insulin* 
measurement on post-mortem blood, but especially of 
vitreous humour, may help resolve the issue, especially 
if carried out within 24–48 hours of death. Caution in 
interpretation of the results is however required especially if 
immunoassay rather than LC-MS is used.
In at least one case known to the authors a misdiagnosis 
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of suicide rather than accidental death was only averted 
when one of the authors (VM) pointed out to the coroner 
that the unexpectedly high post-mortem serum IRI level 
was due to therapeutic use of levermir rather than to 
suicidal overdosing with insulin. With the introduction of 
LC-MS measurements for insulin in all forensic cases such 
errors are unlikely to occur.
Unlike most toxic substances—which are taken by 
mouth—the concentration of insulin in the blood of a 
patient, whether alive or deceased, is a poor indicator of the 
amount of the drug administered. More informative is the 
dose and duration of intravenous glucose administration 
to prevent relapse—providing insulin is known from 
biochemical analysis to be the cause of the patient’s 
hypoglycaemia. With accidental over-dosage the amount 
required is always small (less than 50 grams) and of short 
duration (less than 6 hours) whereas in deliberate or 
malicious administration the glucose dose is bigger and the 
duration longer.
The average requirement of glucose till full recovery 
may be anywhere between 160 and 1,100 g and the duration 
of treatment might vary from 12 to 62 hours or more. 
This has led to the misconception that the requirement for 
large, continuous infusions of glucose to prevent relapse 
into hypoglycaemia is invariably due to malicious insulin 
administration, even when there was no direct evidence of 
insulin involvement. As a result, there have been wrongful 
convictions for murder (7). Similar needs for glucose are 
occasionally seen in non-insulin mediated spontaneous 
hypoglycaemia (1).
Clustered hypoglycaemia
Clustered hypoglycaemia, the occurrence of three or 
more cases of unexpected hypoglycaemia, in a confined 
environment within a short period of one another, may be 
spontaneous or malicious in origin. The earliest clusters 
recorded were due to the ingestion of natural toxins such 
as toxic mushrooms and unripe Akee nuts. Other clusters 
have been due to accidental or deliberate contamination of 
medicinal drugs with sulphonylureas and due to deliberate 
poisoning of patients with insulin in hospitals and care 
homes. Deliberate poisoning of patients presents a number 
of problems including establishing the perpetrator and 
determining, in retrospect, which patients who died with 
hypoglycaemia were due to poisoning and which were due 
to natural causes. It is upon such unreliable information that 
jurists must often make life-changing decisions.
The role of the expert witness
The role of the expert witness is to assist the court 
regardless of whether they are called by the prosecution 
or defence. They are there to help the court understand 
the complexity of hypoglycaemia: what it is, how it was 
caused in this particular case and its likely effect on the 
victim or defendant, depending on the nature of the case. 
They are not there primarily to describe evidence that they 
themselves have elicited—although they may do so—since 
that is the role of the so-called “professional” witnesses.
Experts in the forensic aspects, as opposed to clinical 
practice, of hypoglycaemia are drawn from several 
disciplines including toxicology, endocrinology, forensic 
pathology and clinical biochemistry—possibly the most 
important of all. Whatever the expert’s primary discipline 
their written report should be the same regardless of which 
team they may have consulted with as a medico-scientific 
advisor prior to trial.
In the case of a defendant charged with a criminal 
offence the experts would be expected to express an 
opinion on whether the subject did or not suffer from 
neuroglycopenia of sufficient severity to cause temporary 
incapacity to commission a crime; in other words to behave 
as an automaton.
In cases where insulin is suspected of being used as 
an offensive weapon the expert would be expected to 
demonstrate to the court that it was or that it was not used 
in this way. They should not venture an opinion on who 
was or might have been responsible. Nor should they, in 
cross examination, allow themselves to stray from their 
particular area of expertise as has been known to happen and 
admitting to ignorance in response to a question is both more 
honourable and legally correct than attempting to bluff.
Exactly who qualifies as an expert is a moot point there 
is no generally accepted definition. All should enjoy high 
regard in their primary profession; some will belong to 
the Academy of Experts—a body widely respected by the 
judiciary others to the Society of Expert Witnesses—a 
professional association of those accustomed to giving expert 
advice in court—but most will just be knowledgeable about 
the subject of their expertise in this case hypoglycaemia.
Anyone whose expertise is unchallenged can describe 
themselves as an expert and what they have to say will 
be taken into account in the judge’s summing up. It is 
therefore the responsibility of the opposing legal team—
guided by their own experts—to expose any shortcomings 
in the expertise of any purported expert called by the other 
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side. The ability to do this well and without incurring the 





Provenance and Peer Review: This article was commissioned 
by the editorial office, Journal of Laboratory and Precision 
Medicine for the series “Adult Spontaneous Hypoglycaemia”. 
The article has undergone external peer review.
Reporting Checklist: The authors have completed the 
Narrative Review reporting checklist. Available at http://
dx.doi.org/10.21037/jlpm-20-104
Conflicts of Interest: Both authors have completed the 
ICMJE uniform disclosure form (available at http://dx.doi.
org/10.21037/jlpm-20-104). The series “Adult Spontaneous 
Hypoglycaemia” was commissioned by the editorial office 
without any funding or sponsorship. RG serves as an unpaid 
Guest Editor of the series and serves as an unpaid editorial 
board member of Journal of Laboratory and Precision Medicine 
from March 2020 to March 2022. The other author has no 
other conflicts of interest to declare.
Ethical Statement: The authors are accountable for all 
aspects of the work in ensuring that questions related 
to the accuracy or integrity of any part of the work are 
appropriately investigated and resolved.
Open Access Statement: This is an Open Access article 
distributed in accordance with the Creative Commons 
Attribution-NonCommercial-NoDerivs 4.0 International 
License (CC BY-NC-ND 4.0), which permits the non-
commercial replication and distribution of the article with 
the strict proviso that no changes or edits are made and the 
original work is properly cited (including links to both the 
formal publication through the relevant DOI and the license). 
See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
1. Marks V. Forensic Aspects of Hypoglycaemia. Boca Raton 
CRC Press 2019:1-375.
2. Frier BM. Hypoglycaemia and criminal responsibility. In: 
Andreani D, Marks V, Lefebvre PJ. editors. Hypoglycemia. 
Serono Symposia Publications. New York: Raven Press, 
1987:201-9.
3. Marks V. Hypoglycaemia and automatism. Med Sci Law 
2015;55:186-93.
4. Marks V. Hypoglycaemia--real and unreal, lawful 
and unlawful: the 1994 Banting Lecture. Diabet Med 
1995;12:850-64.
5. Brun JF, Fedou C, Mercier J. Postprandial reactive 
hypoglycemia. Diabetes Metab 2000;26:337-51.
6. Mongraw-Chaffin M, Beavers DP, McClain DA. 
Hypoglycemic symptoms in the absence of diabetes: pilot 
evidence of clinical hypoglycemia in young women. J Clin 
Transl Endocrinol 2019;18:100202.
7. Inside Justice. A Jury blinded by Science: the case of Colin 
Noris. Southampton: Botley Mills, 2013.
8. Thevis M, Thomas A, Delahaut P, et al. Qualitative 
determination of synthetic analogues of insulin in 
human plasma by immunoaffinity purification and liquid 
chromatography-tandem mass spectrometry for doping 
control purposes. Anal Chem 2005;77:3579-85.
9. Hess C, Madea B, Daldrup T, et al. Determination 
of hypoglycaemia induced by insulin or its synthetic 
analogues post mortem. Drug Test Anal 2013;5:802-7.
10. Legg KM, Labay LM, Aiken SS, et al. Validation of a fully 
automated immunoaffinity workflow for the detection 
and quantification of insulin analogs by LC-MS-MS in 
postmortem vitreous humor. J Anal Toxicol  
2019;43:505-11.
11. Hirata Y. Autoimmune insulin syndrome “up to date”. In: 
Andreani D, Marks V, Lefebvre PJ. editors. Hypoglycemia. 
Serono Symposia Publications. New York: Raven Press, 
1987:105-18.
12. Church D, Cardoso L, Bradbury S, et al. Diagnosis of 
insulin autoimmune syndrome using polyethylene glycol 
precipitation and gel filtration chromatography with ex 
vivo insulin exchange. Clin Endocrinol (Oxf)  
2017;86:347-53.
13. Villaume C, Dollet JM, Beck B, et al. Hyperinsulinemia 
associated with normal C-peptide levels in a woman treated 
with isoniazide. Biomed Pharmacother 1982;36:32-5.
14. Constan L, Mako M, Juhn D, et al. The excretion of 
proinsulin and insulin in urine. Diabetologia  
1975;11:119-23.
15. Barbara G, Mégarbane B, Argaud L, et al. Functional 
outcome of patients with prolonged hypoglycemic 
encephalopathy. Ann Intensive Care 2017;7:54.
Journal of Laboratory and Precision Medicine, 2021Page 10 of 10
© Journal of Laboratory and Precision Medicine. All rights reserved.  J Lab Precis Med 2021;6:11 | http://dx.doi.org/10.21037/jlpm-20-104
16. Yorker BC, Kizer KW, Lampe P, et al. Serial murder by 
healthcare professionals. J Forensic Sci 2006;51:1362-71.
17. Field J, Pearson A. Caring to death: the murder of patients 
by nurses. Int J Nurs Pract 2010;16:301-9.
18. Birkinshaw VJ, Gurd MR, Randall SS, et al. Investigations 
in a case of murder by insulin poisoning. Br Med J 
1958;2:463-8.
19. Wunder C, Kauert GF, Toennes SW. Factors leading 
to the degradation/loss of insulin in postmortem blood 
samples. Forensic Sci Int 2014;241:173-7.
20. Palmiere C, Sabatasso S, Torrent C, et al. Post-mortem 
determination of insulin using chemiluminescence 
enzyme immunoassay: preliminary results. Drug Test Anal 
2015;7:797-803.
21. Sahajpal NS, Jain S, Vig V, et al. Insulin in the vitreous 
humor of patients with proliferative diabetic retinopathy. 
Invest Ophthalmol Vis Sci 2018;59:abstr 5366.
22. Tong F, Wu R, Huang W, et al. Forensic aspects 
of homicides by insulin overdose. Forensic Sci Int 
2017;278:9-15.
23. Lutz R, Pedal I, Wetzel C, et al. Insulin injection sites: 
morphology and immunohistochemistry. Forensic Sci Int 
1997;90:93-101.
24. Heyndrickx A, Van Peteghem C, Van den Heede M, et 
al. Insulin murders: isolation and identification by radio-
immunoassay after several months of inhumation. In: 
Oliver JS. editor. Forensic toxicology. Boston: Springer, 
1980:48-57.
25. Suh SW, Gum ET, Hamby AM, et al. Hypoglycemic 
neuronal death is triggered by glucose reperfusion and 
activation of neuronal NADPH oxidase. J Clin Invest 
2007;117:910-8.
26. Mégarbane B, Deye N, Bloch V, et al. Intentional overdose 
with insulin: prognostic factors and toxicokinetic/
toxicodynamic profiles. Crit Care 2007;11:R115.
doi: 10.21037/jlpm-20-104
Cite this article as: Marks V, Gama R. Adult hypoglycaemia; 
a narrative review on forensic aspects.  J Lab Precis Med 
2021;6:11.
